Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 58 | 2023 | 16764 | 2.440 |
Why?
|
Coronary Artery Disease | 21 | 2020 | 6416 | 1.530 |
Why?
|
Plaque, Atherosclerotic | 13 | 2020 | 1483 | 1.020 |
Why?
|
HIV Integrase Inhibitors | 2 | 2023 | 144 | 0.920 |
Why?
|
Intra-Abdominal Fat | 8 | 2021 | 590 | 0.900 |
Why?
|
Adipose Tissue | 6 | 2020 | 3280 | 0.880 |
Why?
|
Amino Acids | 2 | 2018 | 1727 | 0.740 |
Why?
|
Adiposity | 8 | 2019 | 1801 | 0.730 |
Why?
|
Anti-HIV Agents | 7 | 2022 | 4320 | 0.580 |
Why?
|
Growth Hormone | 2 | 2010 | 703 | 0.580 |
Why?
|
Lipoproteins, LDL | 2 | 2018 | 626 | 0.560 |
Why?
|
Serum | 1 | 2016 | 211 | 0.500 |
Why?
|
Inflammation | 11 | 2021 | 10534 | 0.500 |
Why?
|
HIV | 7 | 2019 | 1607 | 0.490 |
Why?
|
Interleukin-10 | 1 | 2020 | 1199 | 0.480 |
Why?
|
Fibrosis | 2 | 2018 | 2024 | 0.480 |
Why?
|
HIV-1 | 6 | 2023 | 6931 | 0.470 |
Why?
|
Human Growth Hormone | 2 | 2009 | 683 | 0.460 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 814 | 0.440 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 6 | 2019 | 293 | 0.440 |
Why?
|
Atherosclerosis | 5 | 2019 | 3401 | 0.430 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1162 | 0.420 |
Why?
|
Anticholesteremic Agents | 2 | 2018 | 979 | 0.420 |
Why?
|
Lipids | 5 | 2014 | 3307 | 0.410 |
Why?
|
Coronary Angiography | 10 | 2019 | 4560 | 0.410 |
Why?
|
RANK Ligand | 1 | 2012 | 325 | 0.380 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 2 | 2008 | 138 | 0.370 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1327 | 0.340 |
Why?
|
Aldosterone | 3 | 2015 | 870 | 0.340 |
Why?
|
Body Composition | 8 | 2019 | 2397 | 0.330 |
Why?
|
Anti-Retroviral Agents | 6 | 2021 | 1734 | 0.330 |
Why?
|
Macrophage Activation | 4 | 2018 | 558 | 0.330 |
Why?
|
Adrenal Glands | 1 | 2010 | 545 | 0.300 |
Why?
|
Calcinosis | 3 | 2012 | 1493 | 0.300 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2022 | 3233 | 0.300 |
Why?
|
Adipocytes, White | 1 | 2007 | 89 | 0.280 |
Why?
|
Adiponectin | 3 | 2008 | 1096 | 0.280 |
Why?
|
Hypolipidemic Agents | 1 | 2011 | 606 | 0.280 |
Why?
|
Dyslipidemias | 2 | 2011 | 851 | 0.270 |
Why?
|
Middle Aged | 53 | 2021 | 212863 | 0.270 |
Why?
|
Carotid Artery, Common | 1 | 2006 | 183 | 0.260 |
Why?
|
Vitamin D | 1 | 2019 | 3197 | 0.260 |
Why?
|
Asymptomatic Diseases | 5 | 2019 | 549 | 0.250 |
Why?
|
Coronary Vessels | 3 | 2016 | 3097 | 0.250 |
Why?
|
Monocytes | 5 | 2018 | 2583 | 0.250 |
Why?
|
Receptors, Cell Surface | 6 | 2019 | 2864 | 0.250 |
Why?
|
Obesity | 4 | 2019 | 12643 | 0.250 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2007 | 592 | 0.240 |
Why?
|
Blood Proteins | 2 | 2020 | 1122 | 0.240 |
Why?
|
Blood Glucose | 5 | 2019 | 6237 | 0.240 |
Why?
|
Antigens, CD | 6 | 2019 | 4024 | 0.230 |
Why?
|
Arteritis | 2 | 2016 | 159 | 0.220 |
Why?
|
Interleukin-18 | 2 | 2021 | 248 | 0.210 |
Why?
|
HIV Integrase | 1 | 2023 | 120 | 0.210 |
Why?
|
Humans | 72 | 2023 | 739398 | 0.210 |
Why?
|
Viral Load | 7 | 2020 | 3299 | 0.210 |
Why?
|
Prolactinoma | 2 | 2021 | 113 | 0.200 |
Why?
|
Male | 52 | 2021 | 349022 | 0.200 |
Why?
|
Adult | 40 | 2021 | 213394 | 0.190 |
Why?
|
Amygdala | 2 | 2019 | 1303 | 0.190 |
Why?
|
Noise, Transportation | 1 | 2021 | 50 | 0.190 |
Why?
|
Female | 48 | 2022 | 378853 | 0.190 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2018 | 2015 | 0.190 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2021 | 11699 | 0.190 |
Why?
|
Case-Control Studies | 10 | 2020 | 21694 | 0.180 |
Why?
|
Placebos | 3 | 2018 | 1678 | 0.180 |
Why?
|
Double-Blind Method | 5 | 2018 | 11985 | 0.180 |
Why?
|
Alanine | 1 | 2022 | 578 | 0.180 |
Why?
|
Proteome | 2 | 2020 | 1772 | 0.170 |
Why?
|
AIDS-Associated Nephropathy | 1 | 2019 | 35 | 0.170 |
Why?
|
Fats | 1 | 2019 | 102 | 0.170 |
Why?
|
CD4 Lymphocyte Count | 5 | 2020 | 2602 | 0.170 |
Why?
|
Caspase 1 | 1 | 2019 | 221 | 0.160 |
Why?
|
Obesity, Abdominal | 2 | 2019 | 360 | 0.160 |
Why?
|
Alanine Transaminase | 1 | 2021 | 591 | 0.160 |
Why?
|
Glipizide | 2 | 2015 | 47 | 0.160 |
Why?
|
Proteomics | 3 | 2020 | 3584 | 0.160 |
Why?
|
Drug Resistance, Viral | 2 | 2023 | 829 | 0.150 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 261 | 0.150 |
Why?
|
Permeability | 1 | 2019 | 739 | 0.150 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2018 | 177 | 0.150 |
Why?
|
Risk Factors | 20 | 2022 | 71974 | 0.140 |
Why?
|
Ergolines | 2 | 2009 | 60 | 0.140 |
Why?
|
Galectin 3 | 1 | 2018 | 226 | 0.140 |
Why?
|
Viral Nonstructural Proteins | 1 | 2018 | 242 | 0.140 |
Why?
|
Subcutaneous Fat | 1 | 2019 | 392 | 0.130 |
Why?
|
Galectins | 1 | 2018 | 266 | 0.130 |
Why?
|
Hyperprolactinemia | 2 | 2009 | 129 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4400 | 0.130 |
Why?
|
Cardiovascular Diseases | 7 | 2020 | 15070 | 0.130 |
Why?
|
Immunoglobulin G | 1 | 2007 | 4522 | 0.130 |
Why?
|
Sex Factors | 6 | 2019 | 10398 | 0.120 |
Why?
|
Absorptiometry, Photon | 2 | 2019 | 1726 | 0.120 |
Why?
|
Body Mass Index | 7 | 2023 | 12655 | 0.120 |
Why?
|
Cytokines | 2 | 2019 | 7298 | 0.120 |
Why?
|
Amino Acids, Aromatic | 1 | 2013 | 30 | 0.120 |
Why?
|
Pituitary Neoplasms | 2 | 2021 | 1334 | 0.120 |
Why?
|
Liver | 2 | 2021 | 7449 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 9 | 2019 | 20055 | 0.120 |
Why?
|
Disease | 1 | 2019 | 683 | 0.110 |
Why?
|
Pericardium | 1 | 2018 | 665 | 0.110 |
Why?
|
Echocardiography, Stress | 1 | 2013 | 131 | 0.110 |
Why?
|
Fluorodeoxyglucose F18 | 5 | 2021 | 2026 | 0.100 |
Why?
|
Osteoprotegerin | 1 | 2012 | 174 | 0.100 |
Why?
|
Hypoglycemic Agents | 2 | 2015 | 2861 | 0.100 |
Why?
|
Weight Gain | 1 | 2022 | 2278 | 0.100 |
Why?
|
Cholesterol | 2 | 2014 | 2900 | 0.100 |
Why?
|
Muscle, Skeletal | 1 | 2007 | 4920 | 0.100 |
Why?
|
Diet | 3 | 2019 | 7876 | 0.100 |
Why?
|
Young Adult | 15 | 2021 | 56255 | 0.100 |
Why?
|
RNA, Viral | 1 | 2020 | 2907 | 0.100 |
Why?
|
Receptor, erbB-2 | 1 | 2021 | 2370 | 0.100 |
Why?
|
Waist Circumference | 2 | 2019 | 912 | 0.100 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2013 | 249 | 0.100 |
Why?
|
Cardiovascular System | 1 | 2018 | 830 | 0.100 |
Why?
|
Metformin | 2 | 2015 | 827 | 0.100 |
Why?
|
Treatment Outcome | 8 | 2019 | 62693 | 0.100 |
Why?
|
Pharmacogenetics | 1 | 2015 | 679 | 0.100 |
Why?
|
Adolescent | 17 | 2021 | 85405 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1891 | 0.090 |
Why?
|
Renin-Angiotensin System | 1 | 2015 | 763 | 0.090 |
Why?
|
Mineralocorticoids | 1 | 2010 | 39 | 0.090 |
Why?
|
Hepacivirus | 1 | 2018 | 1371 | 0.090 |
Why?
|
Interleukin-6 | 2 | 2018 | 3194 | 0.090 |
Why?
|
Antiretroviral Therapy, Highly Active | 5 | 2020 | 1896 | 0.090 |
Why?
|
Intestinal Diseases | 1 | 2015 | 531 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4377 | 0.090 |
Why?
|
Triglycerides | 2 | 2009 | 2447 | 0.090 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 643 | 0.090 |
Why?
|
Prevalence | 7 | 2019 | 15153 | 0.090 |
Why?
|
Cholesterol, LDL | 2 | 2018 | 2334 | 0.090 |
Why?
|
Bone Marrow | 1 | 2019 | 2933 | 0.080 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3036 | 0.080 |
Why?
|
Predictive Value of Tests | 5 | 2019 | 15036 | 0.080 |
Why?
|
Insulin Resistance | 3 | 2019 | 3858 | 0.080 |
Why?
|
Hepatitis C | 1 | 2018 | 1580 | 0.080 |
Why?
|
Heart Valves | 1 | 2009 | 291 | 0.070 |
Why?
|
Abdominal Fat | 1 | 2008 | 223 | 0.070 |
Why?
|
Cross-Sectional Studies | 7 | 2020 | 24714 | 0.070 |
Why?
|
Resistin | 1 | 2007 | 170 | 0.070 |
Why?
|
Drug Interactions | 1 | 2011 | 1456 | 0.070 |
Why?
|
Prospective Studies | 7 | 2021 | 53037 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2018 | 2971 | 0.070 |
Why?
|
Angiography | 3 | 2016 | 1634 | 0.060 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2030 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8400 | 0.060 |
Why?
|
Aorta | 1 | 2012 | 2048 | 0.060 |
Why?
|
Heart | 1 | 2017 | 4466 | 0.060 |
Why?
|
Ultrasonography | 2 | 2008 | 5941 | 0.060 |
Why?
|
Carotid Arteries | 1 | 2008 | 952 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4212 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2010 | 836 | 0.060 |
Why?
|
Hydrocortisone | 1 | 2010 | 1809 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2014 | 12237 | 0.050 |
Why?
|
Hormones | 1 | 2006 | 880 | 0.050 |
Why?
|
Insulin | 3 | 2015 | 6569 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2012 | 5522 | 0.050 |
Why?
|
Coronary Disease | 1 | 2016 | 6068 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2010 | 2100 | 0.050 |
Why?
|
CD4-CD8 Ratio | 1 | 2020 | 112 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5702 | 0.050 |
Why?
|
Neurobiology | 1 | 2021 | 119 | 0.050 |
Why?
|
Oxazines | 1 | 2021 | 302 | 0.040 |
Why?
|
Electrocardiography | 1 | 2013 | 6426 | 0.040 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2021 | 217 | 0.040 |
Why?
|
Aged | 11 | 2021 | 162698 | 0.040 |
Why?
|
Dietary Fats | 1 | 2007 | 2013 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13635 | 0.040 |
Why?
|
Risk Assessment | 4 | 2018 | 23294 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3606 | 0.040 |
Why?
|
Leptin | 1 | 2007 | 1589 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3863 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2009 | 2583 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2008 | 6610 | 0.040 |
Why?
|
HIV Seronegativity | 1 | 2019 | 209 | 0.040 |
Why?
|
Mass Screening | 1 | 2013 | 5265 | 0.040 |
Why?
|
American Heart Association | 2 | 2014 | 1050 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2006 | 6370 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2019 | 441 | 0.040 |
Why?
|
Tomography, X-Ray | 1 | 2016 | 60 | 0.040 |
Why?
|
Macrophages | 1 | 2011 | 5631 | 0.040 |
Why?
|
Adipogenesis | 1 | 2019 | 356 | 0.040 |
Why?
|
Muscle Cells | 1 | 2016 | 196 | 0.030 |
Why?
|
Hemodynamics | 1 | 2006 | 4197 | 0.030 |
Why?
|
Radiography, Abdominal | 1 | 2019 | 535 | 0.030 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2015 | 154 | 0.030 |
Why?
|
Diet Surveys | 1 | 2019 | 1165 | 0.030 |
Why?
|
Nutrition Policy | 1 | 2019 | 486 | 0.030 |
Why?
|
Methylamines | 1 | 2015 | 117 | 0.030 |
Why?
|
Uganda | 1 | 2019 | 1230 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3752 | 0.030 |
Why?
|
Positron-Emission Tomography | 3 | 2016 | 6361 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13880 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2019 | 1437 | 0.030 |
Why?
|
Diet, Sodium-Restricted | 1 | 2015 | 287 | 0.030 |
Why?
|
Prognosis | 3 | 2021 | 28901 | 0.030 |
Why?
|
Quinolines | 1 | 2018 | 721 | 0.030 |
Why?
|
Choline | 1 | 2015 | 488 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2019 | 3701 | 0.030 |
Why?
|
Fasting | 1 | 2019 | 1587 | 0.030 |
Why?
|
Blood Pressure | 1 | 2008 | 8554 | 0.030 |
Why?
|
Chemokine CXCL10 | 1 | 2013 | 302 | 0.030 |
Why?
|
Adipocytes | 1 | 2019 | 1171 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2022 | 1777 | 0.030 |
Why?
|
Angiotensin II | 1 | 2015 | 880 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2021 | 76631 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15511 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2015 | 1149 | 0.030 |
Why?
|
Viral Proteins | 1 | 2019 | 1900 | 0.030 |
Why?
|
Treatment Failure | 1 | 2018 | 2614 | 0.030 |
Why?
|
Tomography, Spiral Computed | 1 | 2013 | 279 | 0.030 |
Why?
|
Weight Loss | 1 | 2003 | 2589 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2013 | 450 | 0.020 |
Why?
|
Spleen | 1 | 2017 | 2359 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2016 | 1858 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2184 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1778 | 0.020 |
Why?
|
Animals | 2 | 2019 | 168368 | 0.020 |
Why?
|
Osteopontin | 1 | 2011 | 295 | 0.020 |
Why?
|
Markov Chains | 1 | 2013 | 970 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4182 | 0.020 |
Why?
|
Hormone Antagonists | 1 | 2009 | 107 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2011 | 618 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2009 | 182 | 0.020 |
Why?
|
Rural Population | 1 | 2019 | 2181 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1603 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57650 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2184 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 38942 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 20913 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6478 | 0.020 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2008 | 92 | 0.020 |
Why?
|
Body Constitution | 1 | 2007 | 273 | 0.020 |
Why?
|
Quality of Life | 1 | 2008 | 12640 | 0.020 |
Why?
|
Prolactin | 1 | 2009 | 668 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2016 | 1571 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9734 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2013 | 1689 | 0.020 |
Why?
|
Cohort Studies | 2 | 2019 | 40389 | 0.020 |
Why?
|
Disease Progression | 2 | 2013 | 13237 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2687 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9314 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2881 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2448 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1890 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5959 | 0.020 |
Why?
|
Hypertriglyceridemia | 1 | 2007 | 294 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2394 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5948 | 0.010 |
Why?
|
Alleles | 1 | 2015 | 6942 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9812 | 0.010 |
Why?
|
United States | 3 | 2021 | 69573 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14740 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10362 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12951 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1364 | 0.010 |
Why?
|
Eating | 1 | 2009 | 1526 | 0.010 |
Why?
|
Contrast Media | 1 | 2014 | 5293 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5959 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18003 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5462 | 0.010 |
Why?
|
Anti-Obesity Agents | 1 | 2003 | 214 | 0.010 |
Why?
|
Energy Intake | 1 | 2007 | 2135 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2009 | 2896 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40050 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16301 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7274 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18349 | 0.010 |
Why?
|
Echocardiography | 1 | 2009 | 5098 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15500 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 7726 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17384 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81002 | 0.010 |
Why?
|
Concepts
(273)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(74)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_